Tong Ren Tang Healthcare Officially Lists on HKEX ｜Patrons Acts as Joint Bookrunner and Joint Lead Manager

On the morning of 7 July 2026, Beijing Tong Ren Tang Healthcare Investment Co., Ltd. (hereinafter referred to as "Tong Ren Tang Healthcare"), stock code 2667.HK, officially listed on the Main Board of The Stock Exchange of Hong Kong Limite at an offer price of HK$5.5 per share. Patrons Financial Holdings served as Joint Bookrunner and Joint Lead Manager in this Global Offering. Leveraging its exceptional capital market service capabilities, Patrons fully assisted Tong Ren Tang’s traditional Chinese medicine (TCM) healthcare division in successfully debuting on the international capital stage.

As a subsidiary of Tong Ren Tang strategically focused on TCM healthcare services in China, Tong Ren Tang Healthcare seamlessly integrates medical care with wellness healthcare, providing modernised and bespoke TCM medical services. According to total outpatient and inpatient volumes in 2024, the enterprise firmly ranks first among non-public TCM hospital groups in China, commanding a market share of 1.7%.

Previously, Tong Ren Tang Healthcare officially launched its public offering from 26 June to 2 July 2026. The Group planned to issue approximately 108 million H-shares within an offer price range of HK$5.48 to HK$6.21 per share, with a maximum estimated net fundraising amount of around HK$671 million.

According to the disclosures in the prospectus, Tong Ren Tang Healthcare intends to allocate the net proceeds from the Global Offering in the following proportions:

• Approximately 47.5% will be used to expand its TCM healthcare service network;

• Approximately 23.6% will be used to enhance its TCM healthcare service capabilities;

• Approximately 18.9% will be utilised to repay certain outstanding bank loans;

• Approximately 10.0% will be allocated for working capital and other general corporate purposes.

As a pioneer in the TCM healthcare sector on the Hong Kong stock market, Tong Ren Tang Healthcare possesses prominent competitive advantages across multiple dimensions:

• Industry Leadership: In terms of total outpatient and inpatient visits in 2024, Tong Ren Tang Healthcare is the largest hospital group in China's non-public TCM healthcare service industry, with a market share of 1.7%.

• Centuries of Brand Heritage: As one of the few TCM healthcare service providers in China with a brand legacy spanning over 350 years, the company leverages the renowned "Tong Ren Tang" brand and premium pharmaceuticals to accumulate and integrate a vast array of online and offline medical resources.

• Hierarchical Network and Resource Synergy: The company has established a hierarchical TCM healthcare service network featuring comprehensive resource coordination and powerful synergistic effects, successfully combining online internet hospitals with offline chain hospitals and primary healthcare institutions to pioneer new possibilities in TCM healthcare services.

Throughout Tong Ren Tang Healthcare's journey towards its Hong Kong IPO, the Patrons Financial Holdings team fully discharged its duties as Joint Bookrunner and Joint Lead Manager.  Possess deep insights into the TCM healthcare services and health products sectors, alongside an extensive international investor network, Patrons tailored a comprehensive, one-stop listing solution. This effectively safeguarded the smooth execution of the IPO, helping Tong Ren Tang Healthcare embark on a crucial new chapter of its international development.

If there is any inconsistency or ambiguity between these two versions, the Chinese version shall prevail.